-
公开(公告)号:US20060252784A1
公开(公告)日:2006-11-09
申请号:US11486348
申请日:2006-07-13
申请人: David Goldstein , Ronald Hawley , Alfred Lui , Eric Sjogren
发明人: David Goldstein , Ronald Hawley , Alfred Lui , Eric Sjogren
IPC分类号: C07D487/14 , A61K31/519
CPC分类号: C07D471/14 , C07D487/14
摘要: The present invention discloses compounds corresponding to formula I: wherein A, Z, Z1, Y, R1 and R2 are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.
摘要翻译: 本发明公开了对应于式I的化合物:其中A,Z,Z 1,Y,R 1和R 2定义如 说明书以及药物制剂,制备方法和用途。
-
公开(公告)号:US20060252783A1
公开(公告)日:2006-11-09
申请号:US11486193
申请日:2006-07-13
申请人: David Goldstein , Ronald Hawley , Alfred Lui , Eric Sjogren
发明人: David Goldstein , Ronald Hawley , Alfred Lui , Eric Sjogren
IPC分类号: C07D487/14 , A61K31/519
CPC分类号: C07D471/14 , C07D487/14
摘要: The present invention discloses compounds corresponding to formula I: wherein A, Z, Z1, Y, R1 and R2 are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.
-
公开(公告)号:US20070049610A1
公开(公告)日:2007-03-01
申请号:US11510015
申请日:2006-08-25
申请人: Michael Dillon , Alam Jahangir , Alfred Lui , Robert Wilhelm
发明人: Michael Dillon , Alam Jahangir , Alfred Lui , Robert Wilhelm
IPC分类号: A61K31/513 , C07D239/46
CPC分类号: C07D401/12 , C07D239/48 , C07D471/04
摘要: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein A, D, E, G, J, X, Y, Z R6, R7 and R8 are as defined herein. Also provided are methods of using the compounds for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist and methods of making the compounds.
摘要翻译: 式I化合物或其药学上可接受的盐,其中A,D,E,G,J,X,Y,ZR 6,R 7和R 0 > 8 SUP>如本文所定义。 还提供了使用该化合物治疗由P2X 3和/或P2X 3/3受体拮抗剂介导的疾病的方法和制备该化合物的方法。
-
公开(公告)号:US20050197352A1
公开(公告)日:2005-09-08
申请号:US11122137
申请日:2005-05-04
申请人: David Goldstein , Ronald Hawley , Alfred Lui , Eric Sjogren
发明人: David Goldstein , Ronald Hawley , Alfred Lui , Eric Sjogren
IPC分类号: A61P11/00 , A61P25/00 , A61P29/00 , C07D471/14 , C07D487/14 , A61K31/519
CPC分类号: C07D471/14 , C07D487/14
摘要: The present invention discloses compounds corresponding to formula I: wherein A, Z, Z1, Y, R1 and R2 are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.
-
-
-